ANALISIS EFEKTIVITAS BIAYA PENGGUNAAN OBAT LANSOPRAZOLE DAN PANTOPRAZOLE PADA PASIEN GASTRITIS RAWAT INAP DI RSPAD GATOT SOEBROTO TAHUN 2019-2023

Anastasya Chanita Putri Maharani, . (2023) ANALISIS EFEKTIVITAS BIAYA PENGGUNAAN OBAT LANSOPRAZOLE DAN PANTOPRAZOLE PADA PASIEN GASTRITIS RAWAT INAP DI RSPAD GATOT SOEBROTO TAHUN 2019-2023. Skripsi thesis, Universitas Pembangunan Nasional Veteran Jakarta.

[img] Text
ABSTRAK.pdf

Download (118kB)
[img] Text
AWAL.pdf

Download (1MB)
[img] Text
BAB 1.pdf
Restricted to Repository UPNVJ Only

Download (198kB)
[img] Text
BAB 2.pdf
Restricted to Repository UPNVJ Only

Download (534kB)
[img] Text
BAB 3.pdf
Restricted to Repository UPNVJ Only

Download (318kB)
[img] Text
BAB 4.pdf
Restricted to Repository UPNVJ Only

Download (406kB)
[img] Text
BAB 5.pdf

Download (186kB)
[img] Text
DAFTAR PUSTAKA.pdf

Download (169kB)
[img] Text
Riwayat Hidup.pdf
Restricted to Repository UPNVJ Only

Download (348kB)
[img] Text
LAMPIRAN.pdf
Restricted to Repository UPNVJ Only

Download (1MB)
[img] Text
HASIL PLAGIARISME.pdf
Restricted to Repository staff only

Download (9MB)
[img] Text
ARTIKEL KI.pdf
Restricted to Repository staff only

Download (356kB)

Abstract

A poor lifestyle is a major risk factor for non-contagious diseases such as gastritis. Gastritis is the most common digestive problem found in health facilities, causing a significant contribution to medical costs and loss of work productivity. The main therapy choice used as treatment for gastritis is proton pump inhibitor (PPI) drugs. The aim of this study was to determine the cost-effectiveness of lansoprazole and pantoprazole using the pharmacoeconomic method of cost-effectiveness analysis. The design of this study is descriptive-analytical with retrospective sampling using medical records from gastritis patients at RSPAD Gatot Soebroto Hospital in 2019-2023. Length of stay is an indicator of effectiveness and compared using the Independent T-Test. Cost-effectiveness was calculated using the Average Cost Effectiveness Ratio (ACER) formula. Based on the research results obtained, the direct medical costs of patients with lansoprazole is Rp 14.037.331,00 with length of stay of 5,10 days, while direct medical costs of pantoprazole is Rp 15.132.378,00 with length of stay of 4,68 days. The length of stay with pantoprazole was shorter but still the difference was not significant (p value = 0.059). In this study, lansoprazole was concluded to be more cost-effective with an ACER value of Rp 2.752.417,84/day compared to pantoprazole with an ACER value of Rp 3.233.414,10/day.

Item Type: Thesis (Skripsi)
Additional Information: [No.Panggil: 2010211043] [Pembimbing 1: Yanti Harjono Hadiwiardjo] [Pembimbing 2: Pritha Maya Savitri] [Penguji: Hany Yusmaini]
Uncontrolled Keywords: Gastritis, Cost Effectiveness, Lansoprazole, Pantoprazole
Subjects: R Medicine > R Medicine (General)
R Medicine > RM Therapeutics. Pharmacology
Divisions: Fakultas Kedokteran > Program Studi Kedokteran (S1)
Depositing User: Anastasya Chanita Putri Maharani
Date Deposited: 18 Mar 2024 02:09
Last Modified: 18 Mar 2024 02:09
URI: http://repository.upnvj.ac.id/id/eprint/27894

Actions (login required)

View Item View Item